These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22488745)

  • 1. Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: Early experience.
    Milot L; Haider M; Foster L; McGregor C; Law C
    J Magn Reson Imaging; 2012 Sep; 36(3):738-42. PubMed ID: 22488745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.
    Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF
    Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined gadoxetic acid and gadofosveset enhanced liver MRI: A feasibility and parameter optimization study.
    Bannas P; Motosugi U; Hernando D; Rahimi MS; Holmes JH; Reeder SB
    Magn Reson Med; 2016 Jan; 75(1):318-28. PubMed ID: 25648403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L; Morana G; Kirchin MA; Schneider G
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Gadolinium Hyperintensity of Suspected Colorectal Liver Metastases on Gadofosveset-Enhanced Magnetic Resonance Imaging: A Predictor of Benignity and a Potential Problem-Solving Tool.
    Cheung HMC; Karanicolas PJ; Coburn N; Law C; Milot L
    Can Assoc Radiol J; 2019 Aug; 70(3):239-245. PubMed ID: 31272725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.
    Tamada T; Ito K; Ueki A; Kanki A; Higaki A; Higashi H; Yamamoto A
    J Magn Reson Imaging; 2012 Apr; 35(4):852-8. PubMed ID: 22127980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.
    Whitney WS; Herfkens RJ; Jeffrey RB; McDonnell CH; Li KC; Van Dalsem WJ; Low RN; Francis IR; Dabatin JF; Glazer GM
    Radiology; 1993 Dec; 189(3):863-70. PubMed ID: 8234717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable?
    Kinner S; Umutlu L; Blex S; Maderwald S; Antoch G; Ertle J; Gerken G; Lauenstein TC
    Eur J Radiol; 2012 Apr; 81(4):e625-8. PubMed ID: 22297185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced whole-heart coronary MRA using Gadofosveset 3.0 T versus 1.5 T.
    Prompona M; Cyran C; Nikolaou K; Bauner K; Reiser M; Huber A
    Acad Radiol; 2010 Jul; 17(7):862-70. PubMed ID: 20399687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
    Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
    Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
    Huppertz A; Kroll H; Klessen C; Taupitz M; Rückert RI; Schröder RJ; Albrecht T; Frericks B; Voth M; Wagner M; Hamm B; Asbach P
    Invest Radiol; 2009 Jul; 44(7):422-32. PubMed ID: 19448555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
    Mahfouz AE; Hamm B; Taupitz M; Wolf KJ
    Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of gadofosveset-enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation.
    Michaely HJ; Attenberger UI; Dietrich O; Schmitt P; Nael K; Kramer H; Reiser MF; Schoenberg SO; Walz M
    Invest Radiol; 2008 Sep; 43(9):635-41. PubMed ID: 18708857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.